Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Ischemic Preconditioning in White Matter: Magnitude and Mechanism.
Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis.
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.
The T-cell immunoglobulin and mucin domain (Tim) gene family in asthma, allergy, and autoimmunity.
Natalizumab Treatment Reduces Fatigue in Multiple Sclerosis. Results from the TYNERGY Trial; A Study in the Real Life Setting.
The effect of ribavirin on reactive astrogliosis in experimental autoimmune encephalomyelitis.
Risk factors for multiple sclerosis: decreased vitamin D level and remote Epstein-Barr virus infection in the pre-clinical phase of multiple sclerosis.
Leukoencephalopathy due to Oral Methotrexate.
Dysphagia in stroke, neurodegenerative disease, and advanced dementia.
Validity and reliability of the Greek version of the Modified Fatigue Impact Scale in multiple sclerosis patients.
Environmental factors and multiple sclerosis severity: a descriptive study.
To be 17 again--anti-interleukin-17 treatment for psoriasis.
Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints.
Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis.
Sexual dysfunction in multiple sclerosis: A 6-year follow-up study.
Multiple sclerosis: the role of cytokines in pathogenesis and in therapies.
Robotic therapy: the tipping point.
Genetic and Infectious Profiles of Japanese Multiple Sclerosis Patients.
Eriocalyxin B ameliorates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells.
[Disruption of the blood-brain barrier in inflammatory neurological diseases].
Autophagy in immunity: Implications in etiology of autoimmune/autoinflammatory diseases.
Is metabolic flexibility altered in multiple sclerosis patients?
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning.
Parent-of-Origin Effects Implicate Epigenetic Regulation of Experimental Autoimmune Encephalomyelitis and Identify Imprinted Dlk1 as a Novel Risk Gene.
Disease activity and disability evolution under glatiramer acetate: A clinical approach.
Pages
« first
‹ previous
…
306
307
308
309
310
311
312
313
314
…
next ›
last »